Suchergebnisse
Compared to Estimates, Sally Beauty (SBH) Q3 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Sally Beauty (SBH) reported revenue of $935.49 million, up 0.2% over the same period last year. EPS came in at $0.55, compared to $0.51 in the year-ago quarter.
The
Compared to Estimates, Marriott (MAR) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Marriott International (MAR) reported revenue of $7.07 billion, up 4.9% over the same period last year. EPS came in at $3.19, compared to $2.65 in the year-ago
Mondelez (MDLZ) Reliance on International Sales: What Investors Need to Know
Did you analyze how Mondelez (MDLZ) fared in its international operations for the quarter ending June 2026? Given the widespread global presence of this maker of Oreo cookies, Cadbury chocolate and
DexCom, Inc. (DXCM) Hit a 52 Week High, Can the Run Continue?
Shares of DexCom (DXCM) have been strong performers lately, with the stock up 17.1% over the past month. The stock hit a new 52-week high of $84.7 in the previous session. DexCom has gained 25.7%
Bowhead Specialty Holdings Inc. (BOW) Q2 Earnings Top Estimates
Bowhead Specialty Holdings Inc. (BOW) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.37 per share a
3 Top Dividend Stocks to Maximize Your Retirement Income
Believe it or not, seniors fear running out of cash more than they fear dying.
Also, retirees who have constructed a nest egg have valid justifications to be concerned, since the traditional ways to
Looking for Computer and Technology Stocks? The Zacks Rank Can Help You Find Winners
Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck.
How do you find the right
TG Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in TG Therapeutics, Inc.? Here are five stocks we like better.
- Strong BRIUMVI growth lifted TG Therapeutics’ outlook: Second-quarter revenue reached $240 million, driven by
Supernus Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Supernus Pharmaceuticals, Inc.? Here are five stocks we like better.
- Supernus and Indivior proposed an all-stock, tax-free merger of equals that would create a
Sportradar Group Q2 Earnings Call Highlights
Key Points
- Interested in Sportradar Group AG? Here are five stocks we like better.
- Strong Q2 performance: Revenue rose 19% to EUR 378 million and adjusted EBITDA increased 19% to EUR 76 million
Marriott International Q2 Earnings Call Highlights
Key Points
- Interested in Marriott International, Inc.? Here are five stocks we like better.
- Marriott exceeded second-quarter expectations: Global RevPAR rose 3.4%, gross fee revenue increased
Lindblad Expeditions Q2 Earnings Call Highlights
Key Points
- Interested in Lindblad Expeditions? Here are five stocks we like better.
- Strong second-quarter performance: Revenue rose 19% year over year to $199.2 million, while adjusted EBITDA
Krystal Biotech Q2 Earnings Call Highlights
Key Points
- Interested in Krystal Biotech, Inc.? Here are five stocks we like better.
- VYJUVEK sales and earnings increased: Second-quarter revenue rose 24% year over year to $119.2 million
Indivior Q2 Earnings Call Highlights
Key Points
- Interested in Indivior PLC? Here are five stocks we like better.
- Indivior and Supernus plan an all-stock merger of equals expected to close in Q4 2026, subject to approvals. The
Compugen Q2 Earnings Call Highlights
Key Points
- Interested in Compugen Ltd.? Here are five stocks we like better.
- COM701’s MAIA-ovarian trial continues enrolling, with an interim analysis including median progression-free survival
American Bitcoin Q2 Earnings Call Highlights
Key Points
- Interested in American Bitcoin Corp.? Here are five stocks we like better.
- Record production: American Bitcoin mined 932 Bitcoin in Q2, up 14% sequentially, while revenue rose 8% to
Wall Street Analysts See a 41.62% Upside in XP Inc.A (XP): Can the Stock Really Move This High?
XP Inc.A (XP) closed the last trading session at $17.06, gaining 5.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
ETFs to Watch as HOOD Sinks Despite Q2 Earnings Beat, Better Cash Position
Shares of Robinhood Markets HOOD slipped 3.6% on July 30, following its better-than-expected second-quarter 2026 results. The trading platform, despite beating Wall Street expectations for both
Can Dolby's Fiscal Q4 Growth Outlook Overcome Licensing Volatility?
Dolby Laboratories, Inc. DLB expects a sharp fiscal fourth-quarter rebound after third-quarter revenues fell 3.3% year over year to $305 million. The guidance midpoint points to approximately 23%